Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 357 entries
Sorted by: Best Match Show Resources per page
The causal impact of ART on NCDs: leveraging quasi-experiments

quasi-experiments

Manne-Goehler J, Geldsetzer P.
GSID: FkJ-wmg6sJoJ
J Manne-Goehler, P Geldsetzer… - The Lancet Diabetes & …, 2017 - thelancet.com

Lancet Diabetes & Endocrinology, which highlights the challenges of building health systems to provide effective chronic care for both HIV and noncommunicable diseases (NCDs) in sub-Saharan Africa. 1 We agree that “the lynchpin of a successful effort to grow...

Cite
Manne-Goehler, J., Geldsetzer, P., & Bärnighausen, T. (2017). The causal impact of ART on NCDs: leveraging quasi-experiments. The Lancet Diabetes & Endocrinology, 5(1), 14.
Manne-Goehler, Jennifer, Pascal Geldsetzer, and Till Bärnighausen. "The causal impact of ART on NCDs: leveraging quasi-experiments." The Lancet Diabetes & Endocrinology 5.1 (2017): 14.
Copy Download .nbib Format: MLA
The need to focus on primary health care for chronic diseases.

The lancet. Diabetes & endocrinology

Beran D, Chappuis F, Cattacin S, Damasceno A, Jha N, Somerville C, Suggs LS, Miranda JJ.
PMID: 27432550
Lancet Diabetes Endocrinol. 2016 Sep;4(9):731-732. doi: 10.1016/S2213-8587(16)30148-6. Epub 2016 Jul 16.

No abstract available.

Cite
Beran D, Chappuis F, Cattacin S, et al. The need to focus on primary health care for chronic diseases. Lancet Diabetes Endocrinol. 2016;4(9):731-732doi: 10.1016/S2213-8587(16)30148-6.
Beran, D., Chappuis, F., Cattacin, S., Damasceno, A., Jha, N., Somerville, C., Suggs, L. S., Miranda, J. J. (2016). The need to focus on primary health care for chronic diseases. The lancet. Diabetes & endocrinology, 4(9), 731-732. https://doi.org/10.1016/S2213-8587(16)30148-6
Beran, David, et al. "The need to focus on primary health care for chronic diseases." The lancet. Diabetes & endocrinology vol. 4,9 (2016): 731-732. doi: https://doi.org/10.1016/S2213-8587(16)30148-6
Beran D, Chappuis F, Cattacin S, Damasceno A, Jha N, Somerville C, Suggs LS, Miranda JJ. The need to focus on primary health care for chronic diseases. Lancet Diabetes Endocrinol. 2016 Sep;4(9):731-732. doi: 10.1016/S2213-8587(16)30148-6. Epub 2016 Jul 16. PMID: 27432550.
Copy Download .nbib Format: NLM
Challenges of monitoring global diabetes prevalence.

The lancet. Diabetes & endocrinology

Ezzati M, Zhou B, Riley L, Stevens GA, Hajifathalian K, Danaei G.
PMID: 28235490
Lancet Diabetes Endocrinol. 2017 Mar;5(3):162. doi: 10.1016/S2213-8587(17)30036-0.

No abstract available.

Cite
Ezzati M, Zhou B, Riley L, et al. Challenges of monitoring global diabetes prevalence. Lancet Diabetes Endocrinol. 2017;5(3):162doi: 10.1016/S2213-8587(17)30036-0.
Ezzati, M., Zhou, B., Riley, L., Stevens, G. A., Hajifathalian, K., Danaei, G. (2017). Challenges of monitoring global diabetes prevalence. The lancet. Diabetes & endocrinology, 5(3), 162. https://doi.org/10.1016/S2213-8587(17)30036-0
Ezzati, Majid, et al. "Challenges of monitoring global diabetes prevalence." The lancet. Diabetes & endocrinology vol. 5,3 (2017): 162. doi: https://doi.org/10.1016/S2213-8587(17)30036-0
Ezzati M, Zhou B, Riley L, Stevens GA, Hajifathalian K, Danaei G. Challenges of monitoring global diabetes prevalence. Lancet Diabetes Endocrinol. 2017 Mar;5(3):162. doi: 10.1016/S2213-8587(17)30036-0. PMID: 28235490.
Copy Download .nbib Format: NLM
Challenges of monitoring global diabetes prevalence - Authors' reply.

The lancet. Diabetes & endocrinology

Bennett PH, Magliano DJ, Alberti KG, Zimmet P.
PMID: 28235491
Lancet Diabetes Endocrinol. 2017 Mar;5(3):162. doi: 10.1016/S2213-8587(17)30037-2.

No abstract available.

Cite
Bennett PH, Magliano DJ, Alberti KG, et al. Challenges of monitoring global diabetes prevalence - Authors' reply. Lancet Diabetes Endocrinol. 2017;5(3):162doi: 10.1016/S2213-8587(17)30037-2.
Bennett, P. H., Magliano, D. J., Alberti, K. G., & Zimmet, P. (2017). Challenges of monitoring global diabetes prevalence - Authors' reply. The lancet. Diabetes & endocrinology, 5(3), 162. https://doi.org/10.1016/S2213-8587(17)30037-2
Bennett, Peter H, et al. "Challenges of monitoring global diabetes prevalence - Authors' reply." The lancet. Diabetes & endocrinology vol. 5,3 (2017): 162. doi: https://doi.org/10.1016/S2213-8587(17)30037-2
Bennett PH, Magliano DJ, Alberti KG, Zimmet P. Challenges of monitoring global diabetes prevalence - Authors' reply. Lancet Diabetes Endocrinol. 2017 Mar;5(3):162. doi: 10.1016/S2213-8587(17)30037-2. PMID: 28235491.
Copy Download .nbib Format: NLM
Correction to Lancet Diabetes Endocrinol 2016; 4: 233-43.

The lancet. Diabetes & endocrinology

[No authors listed]
PMID: 29475499
Lancet Diabetes Endocrinol. 2018 Mar;6(3):e3. doi: 10.1016/S2213-8587(18)30053-6.

No abstract available.

Cite
Correction to Lancet Diabetes Endocrinol 2016; 4: 233-43. Lancet Diabetes Endocrinol. 2018;6(3):e3doi: 10.1016/S2213-8587(18)30053-6.
(2018). Correction to Lancet Diabetes Endocrinol 2016; 4: 233-43. The lancet. Diabetes & endocrinology, 6(3), e3. https://doi.org/10.1016/S2213-8587(18)30053-6
"Correction to Lancet Diabetes Endocrinol 2016; 4: 233-43." The lancet. Diabetes & endocrinology vol. 6,3 (2018): e3. doi: https://doi.org/10.1016/S2213-8587(18)30053-6
Correction to Lancet Diabetes Endocrinol 2016; 4: 233-43. Lancet Diabetes Endocrinol. 2018 Mar;6(3):e3. doi: 10.1016/S2213-8587(18)30053-6. PMID: 29475499.
Copy Download .nbib Format: NLM
Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition.

The lancet. Diabetes & endocrinology

Ratziu V.
PMID: 24795242
Lancet Diabetes Endocrinol. 2014 May;2(5):354-6. doi: 10.1016/S2213-8587(14)70028-2. Epub 2014 Feb 17.

No abstract available.

Cite
Ratziu V. Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition. Lancet Diabetes Endocrinol. 2014;2(5):354-6doi: 10.1016/S2213-8587(14)70028-2.
Ratziu, V. (2014). Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition. The lancet. Diabetes & endocrinology, 2(5), 354-6. https://doi.org/10.1016/S2213-8587(14)70028-2
Ratziu, Vlad. "Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition." The lancet. Diabetes & endocrinology vol. 2,5 (2014): 354-6. doi: https://doi.org/10.1016/S2213-8587(14)70028-2
Ratziu V. Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition. Lancet Diabetes Endocrinol. 2014 May;2(5):354-6. doi: 10.1016/S2213-8587(14)70028-2. Epub 2014 Feb 17. PMID: 24795242.
Copy Download .nbib Format: NLM
Translating global commitments on NCDs into national action: the role of civil society.

The lancet. Diabetes & endocrinology

Dain K, Parsons-Perez C, John S, Watt J.
PMID: 26598330
Lancet Diabetes Endocrinol. 2016 Jan;4(1):12-4. doi: 10.1016/S2213-8587(15)00434-9. Epub 2015 Nov 16.

No abstract available.

Cite
Dain K, Parsons-Perez C, John S, et al. Translating global commitments on NCDs into national action: the role of civil society. Lancet Diabetes Endocrinol. 2015;4(1):12-4doi: 10.1016/S2213-8587(15)00434-9.
Dain, K., Parsons-Perez, C., John, S., & Watt, J. (2016). Translating global commitments on NCDs into national action: the role of civil society. The lancet. Diabetes & endocrinology, 4(1), 12-4. https://doi.org/10.1016/S2213-8587(15)00434-9
Dain, Katie, et al. "Translating global commitments on NCDs into national action: the role of civil society." The lancet. Diabetes & endocrinology vol. 4,1 (2016): 12-4. doi: https://doi.org/10.1016/S2213-8587(15)00434-9
Dain K, Parsons-Perez C, John S, Watt J. Translating global commitments on NCDs into national action: the role of civil society. Lancet Diabetes Endocrinol. 2016 Jan;4(1):12-4. doi: 10.1016/S2213-8587(15)00434-9. Epub 2015 Nov 16. PMID: 26598330.
Copy Download .nbib Format: NLM
China Diabetes Society 2016: a call for papers.

The lancet. Diabetes & endocrinology

Davies J, Wang H, Jia W.
PMID: 26639558
Lancet Diabetes Endocrinol. 2016 Jan;4(1):14-5. doi: 10.1016/S2213-8587(15)00465-9. Epub 2015 Nov 28.

No abstract available.

Cite
Davies J, Wang H, Jia W. China Diabetes Society 2016: a call for papers. Lancet Diabetes Endocrinol. 2015;4(1):14-5doi: 10.1016/S2213-8587(15)00465-9.
Davies, J., Wang, H., & Jia, W. (2016). China Diabetes Society 2016: a call for papers. The lancet. Diabetes & endocrinology, 4(1), 14-5. https://doi.org/10.1016/S2213-8587(15)00465-9
Davies, Justine, et al. "China Diabetes Society 2016: a call for papers." The lancet. Diabetes & endocrinology vol. 4,1 (2016): 14-5. doi: https://doi.org/10.1016/S2213-8587(15)00465-9
Davies J, Wang H, Jia W. China Diabetes Society 2016: a call for papers. Lancet Diabetes Endocrinol. 2016 Jan;4(1):14-5. doi: 10.1016/S2213-8587(15)00465-9. Epub 2015 Nov 28. PMID: 26639558.
Copy Download .nbib Format: NLM
Correction to Lancet Diabetes Endocrinol 2016; 4: 756-65.

The lancet. Diabetes & endocrinology

[No authors listed]
PMID: 28958699
Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7. doi: 10.1016/S2213-8587(17)30330-3. Epub 2017 Sep 22.

No abstract available.

Cite
Correction to Lancet Diabetes Endocrinol 2016; 4: 756-65. Lancet Diabetes Endocrinol. 2017;5(11):e7doi: 10.1016/S2213-8587(17)30330-3.
(2017). Correction to Lancet Diabetes Endocrinol 2016; 4: 756-65. The lancet. Diabetes & endocrinology, 5(11), e7. https://doi.org/10.1016/S2213-8587(17)30330-3
"Correction to Lancet Diabetes Endocrinol 2016; 4: 756-65." The lancet. Diabetes & endocrinology vol. 5,11 (2017): e7. doi: https://doi.org/10.1016/S2213-8587(17)30330-3
Correction to Lancet Diabetes Endocrinol 2016; 4: 756-65. Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7. doi: 10.1016/S2213-8587(17)30330-3. Epub 2017 Sep 22. PMID: 28958699.
Copy Download .nbib Format: NLM
Diabetes: time for real action.

The lancet. Diabetes & endocrinology

The Lancet Diabetes Endocrinology.
PMID: 27016319
Lancet Diabetes Endocrinol. 2016 Apr;4(4):287-8. doi: 10.1016/S2213-8587(16)00087-5.

No abstract available.

Cite
The Lancet Diabetes Endocrinology. Diabetes: time for real action. Lancet Diabetes Endocrinol. 2016;4(4):287-8doi: 10.1016/S2213-8587(16)00087-5.
The Lancet Diabetes Endocrinology. (2016). Diabetes: time for real action. The lancet. Diabetes & endocrinology, 4(4), 287-8. https://doi.org/10.1016/S2213-8587(16)00087-5
The Lancet Diabetes Endocrinology. "Diabetes: time for real action." The lancet. Diabetes & endocrinology vol. 4,4 (2016): 287-8. doi: https://doi.org/10.1016/S2213-8587(16)00087-5
The Lancet Diabetes Endocrinology. Diabetes: time for real action. Lancet Diabetes Endocrinol. 2016 Apr;4(4):287-8. doi: 10.1016/S2213-8587(16)00087-5. PMID: 27016319.
Copy Download .nbib Format: NLM
Country in Focus: diabetes epidemic poses challenge for health care in India.

The lancet. Diabetes & endocrinology

Bagcchi S.
PMID: 26825234
Lancet Diabetes Endocrinol. 2016 Feb;4(2):101-2. doi: 10.1016/S2213-8587(16)00008-5.

No abstract available.

Cite
Bagcchi S. Country in Focus: diabetes epidemic poses challenge for health care in India. Lancet Diabetes Endocrinol. 2016;4(2):101-2doi: 10.1016/S2213-8587(16)00008-5.
Bagcchi, S. (2016). Country in Focus: diabetes epidemic poses challenge for health care in India. The lancet. Diabetes & endocrinology, 4(2), 101-2. https://doi.org/10.1016/S2213-8587(16)00008-5
Bagcchi, Sanjeet. "Country in Focus: diabetes epidemic poses challenge for health care in India." The lancet. Diabetes & endocrinology vol. 4,2 (2016): 101-2. doi: https://doi.org/10.1016/S2213-8587(16)00008-5
Bagcchi S. Country in Focus: diabetes epidemic poses challenge for health care in India. Lancet Diabetes Endocrinol. 2016 Feb;4(2):101-2. doi: 10.1016/S2213-8587(16)00008-5. PMID: 26825234.
Copy Download .nbib Format: NLM
Possible differences in fetal size by racial origin.

The lancet. Diabetes & endocrinology

Steer PJ.
PMID: 25009083
Lancet Diabetes Endocrinol. 2014 Oct;2(10):766-7. doi: 10.1016/S2213-8587(14)70157-3. Epub 2014 Jul 06.

No abstract available.

Cite
Steer PJ. Possible differences in fetal size by racial origin. Lancet Diabetes Endocrinol. 2014;2(10):766-7doi: 10.1016/S2213-8587(14)70157-3.
Steer, P. J. (2014). Possible differences in fetal size by racial origin. The lancet. Diabetes & endocrinology, 2(10), 766-7. https://doi.org/10.1016/S2213-8587(14)70157-3
Steer, Philip J. "Possible differences in fetal size by racial origin." The lancet. Diabetes & endocrinology vol. 2,10 (2014): 766-7. doi: https://doi.org/10.1016/S2213-8587(14)70157-3
Steer PJ. Possible differences in fetal size by racial origin. Lancet Diabetes Endocrinol. 2014 Oct;2(10):766-7. doi: 10.1016/S2213-8587(14)70157-3. Epub 2014 Jul 06. PMID: 25009083.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 357 entries